Market Place
Sourcing Support
Actio Biosciences Joins Piper Sandler Spring Biopharma Symposium
09 Apr 2025 //
BUSINESSWIRE
Actio Doses First Patient in Ph 1 ABS-0871 Trial for CMT2C
03 Mar 2025 //
BUSINESSWIRE
Actio Bio to Participate in Upcoming Investor Conferences
25 Feb 2025 //
BUSINESSWIRE
Actio Biosciences Appoints Cayce Denton As Chief Financial Officer
08 Jan 2025 //
BUSINESSWIRE
Actio Biosciences to Present at 43rd Annual J.P. Morgan Conference
06 Jan 2025 //
BUSINESSWIRE
Actio Biosciences to Participate in Upcoming Investor Conferences
12 Nov 2024 //
BUSINESSWIRE
Actio Biosciences To Join October Investor Conferences
25 Sep 2024 //
BUSINESSWIRE
Actio Biosciences Appoints Dimitrios Arkilo As Chief Medical Officer
20 Aug 2024 //
BUSINESSWIRE
Emil Kakkis Joins Actio Biosciences Board Of Directors
17 Jul 2024 //
BUSINESSWIRE
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
22 May 2024 //
BUSINESSWIRE
Actio Biosciences Appoints Samuel Collins as Chief Medical Officer
24 Jan 2024 //
BUSINESSWIRE
Actio Biosciences Announces $55 Million Series A Financing
12 Sep 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.